Intracranial phosphaturic mesenchymal tumor: A rare case report and systematic review

Shuyue Song1, Yuyang Zhao1, Yiquan Wang1

  • 1School of Clinical Medicine, Shandong Second Medical University, Weifang, China.

Medicine
|February 24, 2025
PubMed
Abstract

Insights

Phosphaturic mesenchymal tumors (PMTs) are rare intracranial tumors often misdiagnosed. Early diagnosis and surgical resection are crucial for successful treatment and symptom resolution.

Area of Science:

  • Neurosurgery
  • Oncology
  • Pathology

Background:

  • Phosphaturic mesenchymal tumors (PMTs) are rare neoplasms with potential intracranial involvement.
  • Their low incidence, nonspecific symptoms, and varied appearance lead to frequent misdiagnosis.

Purpose of the Study:

  • To report a rare case of an intracranial PMT in the posterior cranial fossa.
  • To systematically review and summarize existing literature on intracranial PMTs.

Main Methods:

  • Diagnosis was confirmed through pathological examination, integrating clinical, laboratory, and imaging data.
  • A systematic literature review was performed to gather data on previously reported cases.

Main Results:

  • The patient underwent multidisciplinary consultations and surgical tumor resection.
  • Post-surgery, the patient experienced normalized laboratory values, symptom improvement, and regained mobility.

Conclusions:

  • Established diagnostic and treatment standards for PMTs are lacking due to their rarity.
  • Prompt identification, accurate diagnosis, and complete surgical resection are vital for optimal outcomes.
  • Adjuvant therapies may be necessary for incomplete resections to manage recurrence and persistent symptoms.